The effects of ELTGOL on muciciliary clearance in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 731s Year: 2006
COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021
Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012
Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007
Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
The effects of ELTGOL on mucociliary clearance in patients with COPD Source: Eur Respir Rev 2006; 15: 192-193 Year: 2006
Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
The complexities of patients with COPD Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II Year: 2014
Mortality of patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 631s Year: 2007
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016
Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
Anemia in COPD patients with an exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011
Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Neutrophils and spirometry changes in COPD patients treated with roflumilast Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
The condition of mucociliary clearance in people with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
The course of disease of patients who died from asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020